Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2025)

Sutro Biopharma's Asset Utilization Ratio history spans 8 years, with the latest figure at 0.45 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 37.59% year-over-year to 0.45; the TTM value through Sep 2025 reached 0.45, up 37.59%, while the annual FY2024 figure was 0.14, 58.71% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.45 at Sutro Biopharma, up from 0.36 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.45 in Q3 2025 and bottomed at 0.11 in Q3 2023.
  • The 5-year median for Asset Utilization Ratio is 0.17 (2021), against an average of 0.22.
  • The largest annual shift saw Asset Utilization Ratio soared 199.85% in 2024 before it crashed 62.51% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.17 in 2021, then dropped by 3.33% to 0.17 in 2022, then skyrocketed by 103.0% to 0.34 in 2023, then tumbled by 62.12% to 0.13 in 2024, then soared by 246.89% to 0.45 in 2025.
  • Per Business Quant, the three most recent readings for STRO's Asset Utilization Ratio are 0.45 (Q3 2025), 0.36 (Q2 2025), and 0.13 (Q1 2025).